Zurich Cantonal Bank
PCRX icon

Zurich Cantonal Bank’s Pacira BioSciences PCRX Stock Holding History

Zurich Cantonal Bank’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,255
Closed -$421K – 3241
2025
Q4 		$421K Buy
+16,255
New +$387K ﹤0.01% 1886

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zurich Cantonal Bank's PCRX Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Pacira BioSciences (PCRX) in Q1 2026: 8,982 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #2241 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in PCRX as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in PCRX in Q1 2015 and has held it in 44 quarters since. The position peaked at $519K in Q1 2022. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Zurich Cantonal Bank held 8,982 shares of Pacira BioSciences worth $203K as of Q1 2026.
  • Pacira BioSciences was a new Zurich Cantonal Bank position in Q1 2026.
  • Pacira BioSciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2241 holding.
  • Zurich Cantonal Bank first reported a position in Pacira BioSciences in Q1 2015 and has held it in 44 quarters since.
  • Zurich Cantonal Bank's Pacira BioSciences position peaked at $519K in Q1 2022.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.